Published in:
Open Access
01-12-2010 | Oral presentation
0315. The pharmacokinetic and safety profile of raltegravir and ribavirin, when dosed separately and together, in healthy volunteers
Authors:
J Ashby, LJ Garvey, OW Erlwein, H Lamba, R Weston, K Legg, MO McClure, L Dickinson, A D'Avolio, DJ Back, A Winston
Published in:
Journal of the International AIDS Society
|
Special Issue 4/2010
Login to get access
Excerpt
Treatment of chronic hepatitis C virus (HCV) infection in HIV-1 co-infected individuals remains challenging due to numerous factors including drug-drug interactions. The aim of this study was to assess the safety and pharmacokinetic (PK) profile of raltegravir, a recently licensed antiretroviral agent, and ribavirin, when dosed separately and together. …